These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20958883)

  • 21. [Severe hyponatremia by oxcarbazepine in an elderly].
    Valentini S; Arbaizar-Rodríguez P; Abarca-Costalago M; Valdivielso-Felices P; González-Santos P
    Rev Neurol; 2009 Jun 1-15; 48(11):614-5. PubMed ID: 19472164
    [No Abstract]   [Full Text] [Related]  

  • 22. Oxcarbazepine-induced Stevens-Johnson syndrome: a case report.
    Lin LC; Lai PC; Yang SF; Yang RC
    Kaohsiung J Med Sci; 2009 Feb; 25(2):82-6. PubMed ID: 19321411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenytoin toxicity secondary to an oxcarbazepine-phenytoin 2C19 interaction.
    Soskin DP; Kane AJ; Stern TA
    Psychosomatics; 2010; 51(6):532-5. PubMed ID: 21051688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical, cognitive, and neurophysiologic correlates of short-term treatment with carbamazepine, oxcarbazepine, and levetiracetam in healthy volunteers.
    Mecarelli O; Vicenzini E; Pulitano P; Vanacore N; Romolo FS; Di Piero V; Lenzi GL; Accornero N
    Ann Pharmacother; 2004 Nov; 38(11):1816-22. PubMed ID: 15367726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic drug interactions in children taking oxcarbazepine.
    Sallas WM; Milosavljev S; D'souza J; Hossain M
    Clin Pharmacol Ther; 2003 Aug; 74(2):138-49. PubMed ID: 12891224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxcarbazepine: hyponatraemia and skin reactions.
    Prescrire Int; 2007 Feb; 16(87):18. PubMed ID: 17323525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxcarbazepine in a carbamazepine-intolerant patient with bipolar affective disorder: a case report.
    Kalra H; Dalal PK; Allet L; Janca A
    Psychiatr Danub; 2006 Jun; 18(1-2):90-1. PubMed ID: 16804505
    [No Abstract]   [Full Text] [Related]  

  • 28. Oxcarbazepine and valproic acid-induced lupus in a 7-year-old boy.
    Ozçakar ZB; Yalçinkaya F; Odek C; Ekim M
    Acta Paediatr; 2008 Aug; 97(8):1000-1. PubMed ID: 18474068
    [No Abstract]   [Full Text] [Related]  

  • 29. Reversible parkinsonism with oxcarbazepine use.
    Okuyucu EE; Duman T; Akcin E
    Parkinsonism Relat Disord; 2009 Dec; 15(10):787-8. PubMed ID: 19401271
    [No Abstract]   [Full Text] [Related]  

  • 30. Overnight transition from carbamazepine to oxcarbazepine in children and adolescents.
    Vaisleib II; Neft RA
    Pharmacotherapy; 2008 Oct; 28(10):1211-4. PubMed ID: 18823216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute encephalopathy induced by oxcarbazepine and furosemide.
    Siniscalchi A; Mancuso F; Scornaienghi D; Ferreri G; De Sarro G
    Ann Pharmacother; 2004 Mar; 38(3):509-10. PubMed ID: 14970374
    [No Abstract]   [Full Text] [Related]  

  • 32. The first report of oxcarbazepine-induced vanishing bile duct syndrome.
    Tekin F; Celik F; Nart D; Akarca U
    J Gastrointestin Liver Dis; 2014 Jun; 23(2):222-3. PubMed ID: 24949618
    [No Abstract]   [Full Text] [Related]  

  • 33. Oxcarbazepine-induced leukopenia.
    Milia A; Pilia G; Mascia MG; Moller J; Cocco E; Marrosu MG
    J Neuropsychiatry Clin Neurosci; 2008; 20(4):502-3. PubMed ID: 19196947
    [No Abstract]   [Full Text] [Related]  

  • 34. A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder.
    Hirschfeld RM; Kasper S
    Int J Neuropsychopharmacol; 2004 Dec; 7(4):507-22. PubMed ID: 15458610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central hypothyroidism with oxcarbazepine therapy.
    Miller J; Carney P
    Pediatr Neurol; 2006 Mar; 34(3):242-4. PubMed ID: 16504798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbamazepine-hypersensitivity: assessment of clinical and in vitro chemical cross-reactivity with phenytoin and oxcarbazepine.
    Pirmohamed M; Graham A; Roberts P; Smith D; Chadwick D; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1991 Dec; 32(6):741-9. PubMed ID: 1768568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children.
    Holtmann M; Krause M; Opp J; Tokarzewski M; Korn-Merker E; Boenigk HE
    Neuropediatrics; 2002 Dec; 33(6):298-300. PubMed ID: 12571784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxcarbazepine-related neutropenia: a case report.
    Hsiao YT; Wei IH; Huang CC
    J Clin Psychopharmacol; 2010 Feb; 30(1):94-5. PubMed ID: 20075666
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical profile of oxcarbazepine-related angioneurotic edema: case report and review.
    Knudsen JF; Flowers CM; Kortepeter C; Awaad Y
    Pediatr Neurol; 2007 Aug; 37(2):134-7. PubMed ID: 17675030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible precipitation of myoclonic seizures with oxcarbazepine.
    Kaddurah AK; Holmes GL
    Epilepsy Behav; 2006 Feb; 8(1):289-93. PubMed ID: 16356781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.